ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. We invite you to learn more about how our products and services can help your business by visiting our website: www.immuone.com Follow us on Twitter: @ImmuONE
| Website | http://www.immuone.com |
| Employees | 22 (10 on RocketReach) |
| Founded | 2019 |
| Phone | +44 1707 28417 |
| Technologies |
JavaScript
,
HTML
,
PHP
+21 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Immunology Research, Cell-Based Assays, Pulmonary Research, Tissue Engineering, In Vitro Toxicology, In Vitro Models, Drug Development Testing, Preclinical Testing, Drug Discovery Platform, Regenerative Medicine, Testing Services, Reliable Results, Biomedical Research, Pharmaceutical Research, Research Models |
| Competitors | Novartis, Sanofi, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Immunocore, Adaptimmune, Celyad Oncology, Bellicum Pharmaceuticals, Inc. +40 more (view full list) |
Looking for a particular ImmuONE employee's phone or email?
Abigail Martin is the CEO of ImmuONE.
10 people are employed at ImmuONE.